ImportRefusal LogoImportRefusal

Violation Code: 472

FDA Violation

Charge Code: NO ENGLISH

3,622
Total Refusals
1734
Affected Firms
12/22/2025
Latest Case
10/23/2001
First Case

Violation Details

Violation Code (ASC ID)
472
Charge Code
NO ENGLISH
Description
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
Legal Section
502(c); 801(a)(3) ;MISBRANDING

Most Affected Firms

#Firm NameLocationCases
1Best-pharm Ltd.Moscow, RUSSIA105
2Farm InvestM. Chernivtsi, UKRAINE85
3Fu Sung Pharmaceutaical WorksUnknown, CHINA52
4Productos Medline, S.A. de C.V.Nuevo Laredo, MEXICO47
5MARTINEZ ENVIOS EXPRESS 504Juticalpa, HONDURAS32
6Wyeth Ilaclari AsEsentepe Istanbul, TURKEY31
7Bio Fresh Ltd.Plovdiv, BULGARIA30
8Dr Irena Eris S.A.Piaseczno, POLAND26
9Centro Botanico Azteca SAMexico, MEXICO23
10OMEGA NUTRITIONHidalgo Del Parral, MEXICO22
11Enrique Ordoqui PoseMontevideo, URUGUAY21
12Beiersdorf AGHamburg, GERMANY21
13PHARM-INVEST JVChernovcy-Chemihivska, UKRAINE21
14Best PharmMoscow, RUSSIA21
15Mineralbio Co LtdSeongnam, SOUTH KORE20
16Guangzhou Youxi Cosmetics Co. Ltd.Guangzhou, CHINA19
17CADBURY ADAMS MEXICO, S DE R.L. DE C.V.Delg Cuajimalpa De Morelos, MEXICO18
18E-Pharma Trento SPATrento, ITALY17
19Lab PorAre, PERU16
20Allergan Pharmaceuticals IrelandWestport, IRELAND16

Recent Import Refusals

DateProductFirm
12/22/2025
CALCIUM CHLORIDE, DEXTROSE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, SODIUM LACTATE, PERITONEAL DIALYSIS
64ZBL01
12/18/2025
DAPAGLIFLOZIN (ANTI-DIABETIC)
61PDY70
12/16/2025
MISCELLANEOUS PATENT MEDICINES, ETC.
66VCY99
HU YINGSOUTH KORE
12/12/2025
SUPPRESSANT N.E.C.
66FCY99
Om PharmaSWITZERLAN
12/3/2025
BOVINE (BOVINE AMNIOTIC FLUID) (COSMETIC RAW MATERIAL)
53PB01
BrtITALY
11/21/2025
SYRINGE, PISTON
80FMF
11/21/2025
OMALIZUMAB
58ACP04
11/14/2025
ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
66PBJ99
COSMAX, INC.SOUTH KORE
10/9/2025
EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
66YBY99
10/1/2025
TIRZEPATIDE (ANTI-DIABETIC)
61PCY74
10/1/2025
ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
66PBL99
9/30/2025
MISCELLANEOUS PATENT MEDICINES, ETC.
66VDY99
9/30/2025
SODIUM CHLORIDE (REPLENISHER)
65RCY19
9/22/2025
MISCELLANEOUS PATENT MEDICINES, ETC.
66VIY99
DAVIS SAGUATEMALA
9/22/2025
MISCELLANEOUS PATENT MEDICINES, ETC.
66VIY99

Related Violations

Other violations under the same legal section: 502(c); 801(a)(3) ;MISBRANDING

CodeCharge CodeCases
3870708NOENGL4

Frequently Asked Questions

What is FDA violation code 472?

472 is an FDA violation code that indicates: "Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).". This violation is based on 502(c); 801(a)(3) ;MISBRANDING of the Federal Food, Drug, and Cosmetic Act.

How many import refusals have been issued for violation 472?

According to FDA Import Refusal data, there have been 3622 import refusals issued for violation code 472, affecting 1734 unique firms.

When was the most recent refusal for violation 472?

The most recent import refusal for violation 472 was on December 22, 2025.

What products are commonly refused for violation 472?

Products commonly refused under violation 472 include: CALCIUM CHLORIDE, DEXTROSE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, SODIUM LACTATE, PERITONEAL DIALYSIS, DAPAGLIFLOZIN (ANTI-DIABETIC), MISCELLANEOUS PATENT MEDICINES, ETC., SUPPRESSANT N.E.C., BOVINE (BOVINE AMNIOTIC FLUID) (COSMETIC RAW MATERIAL). These products were refused entry because they did not meet FDA requirements.

What is the legal basis for FDA violation code 472?

Violation code 472 is based on 502(c); 801(a)(3) ;MISBRANDING of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This section of the law establishes requirements that imported products must meet to be allowed entry into the United States.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.